HSPA5 and breast cancer: Furthermore, GRP78 levels were found positively associated with shorter TTR in a cohort of BC patients treated with adriamycin-based chemotherapy and consequently proposed as a predictive factor of poor responsiveness to chemotherapy [11,86].